Article
Inhibition of DHFR targets the self-renewing potential of brain tumor initiating cells
2 Feb 2021
Abstract excerpt
Brain tumors are a heterogeneous group of benign and malignant tumors arising from the brain parenchyma and its surrounding structures, with in general a poor clinical outcome due to high recurrence. One of the underlying causes for this somber prognostic is the presence of brain tumor initiating cells (BTIC) endowed with self-renewal potential, multi-lineage differentiation and resistance to treatment. One...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
